 FLORHAM PARK, N.J., Sept. 13, 2021 GLOBE NEWSWIRE -- PDS Biotechnology Corporation Nasdaq: PDSB, a clinical-stage immunotherapy company developing novel cancer therapies based on the Companys proprietary Versamune T-cell activating technology, announced today that its management will present at the Oppenheimer Fall Healthcare Life Sciences MedTech Summit. 